PL3774745T3 - Kryształ cząsteczki oksazolu - Google Patents
Kryształ cząsteczki oksazoluInfo
- Publication number
- PL3774745T3 PL3774745T3 PL19718465.8T PL19718465T PL3774745T3 PL 3774745 T3 PL3774745 T3 PL 3774745T3 PL 19718465 T PL19718465 T PL 19718465T PL 3774745 T3 PL3774745 T3 PL 3774745T3
- Authority
- PL
- Poland
- Prior art keywords
- compound crystal
- oxazole compound
- oxazole
- crystal
- compound
- Prior art date
Links
- -1 Oxazole compound Chemical class 0.000 title 1
- 239000013078 crystal Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/421—1,3-Oxazoles, e.g. pemoline, trimethadione
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2018072717 | 2018-04-04 | ||
| PCT/JP2019/014730 WO2019194211A1 (en) | 2018-04-04 | 2019-04-03 | Oxazole compound crystal |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3774745T3 true PL3774745T3 (pl) | 2024-08-19 |
Family
ID=66223774
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL19718465.8T PL3774745T3 (pl) | 2018-04-04 | 2019-04-03 | Kryształ cząsteczki oksazolu |
Country Status (26)
| Country | Link |
|---|---|
| US (4) | US11414391B2 (pl) |
| EP (2) | EP4400167A3 (pl) |
| JP (4) | JP7326295B2 (pl) |
| KR (2) | KR102764726B1 (pl) |
| CN (1) | CN111902402B (pl) |
| AU (2) | AU2019249562B2 (pl) |
| BR (1) | BR112020019377A2 (pl) |
| CA (1) | CA3095866A1 (pl) |
| DK (1) | DK3774745T3 (pl) |
| EA (1) | EA202092393A1 (pl) |
| ES (1) | ES2982586T3 (pl) |
| FI (1) | FI3774745T3 (pl) |
| HR (1) | HRP20240858T1 (pl) |
| HU (1) | HUE066793T2 (pl) |
| IL (2) | IL315425A (pl) |
| LT (1) | LT3774745T (pl) |
| MX (1) | MX2020010435A (pl) |
| MY (1) | MY202406A (pl) |
| PH (1) | PH12020551605A1 (pl) |
| PL (1) | PL3774745T3 (pl) |
| PT (1) | PT3774745T (pl) |
| SG (1) | SG11202009564TA (pl) |
| SI (1) | SI3774745T1 (pl) |
| TW (2) | TWI860993B (pl) |
| WO (1) | WO2019194211A1 (pl) |
| ZA (1) | ZA202006134B (pl) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL3774745T3 (pl) * | 2018-04-04 | 2024-08-19 | Otsuka Pharmaceutical Co., Ltd. | Kryształ cząsteczki oksazolu |
| EP4501324A4 (en) | 2022-03-25 | 2026-04-08 | Otsuka Pharma Co Ltd | WOUND TREATMENT COMPOSITION |
| CN115887463A (zh) * | 2022-12-27 | 2023-04-04 | 瑞石生物医药有限公司 | 一种含环酰胺化合物的药物组合物 |
| GB202306663D0 (en) | 2023-05-05 | 2023-06-21 | Union Therapeutics As | Combination therapy |
| US20260076788A1 (en) * | 2024-09-17 | 2026-03-19 | Natalie DeVoir | Orthodontic composition |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI330639B (en) * | 2005-11-15 | 2010-09-21 | Otsuka Pharma Co Ltd | Oxazole compound and pharmaceutical composition |
| EP2890686B1 (en) * | 2012-08-30 | 2017-01-04 | Otsuka Pharmaceutical Co., Ltd. | Method for producing oxazole compound |
| TWI726027B (zh) * | 2015-12-28 | 2021-05-01 | 日商大塚製藥股份有限公司 | 軟膏 |
| PL3774745T3 (pl) * | 2018-04-04 | 2024-08-19 | Otsuka Pharmaceutical Co., Ltd. | Kryształ cząsteczki oksazolu |
-
2019
- 2019-04-03 PL PL19718465.8T patent/PL3774745T3/pl unknown
- 2019-04-03 TW TW108111946A patent/TWI860993B/zh active
- 2019-04-03 PT PT197184658T patent/PT3774745T/pt unknown
- 2019-04-03 JP JP2020539109A patent/JP7326295B2/ja active Active
- 2019-04-03 IL IL315425A patent/IL315425A/en unknown
- 2019-04-03 WO PCT/JP2019/014730 patent/WO2019194211A1/en not_active Ceased
- 2019-04-03 EP EP24172132.3A patent/EP4400167A3/en active Pending
- 2019-04-03 TW TW113146840A patent/TW202515853A/zh unknown
- 2019-04-03 MX MX2020010435A patent/MX2020010435A/es unknown
- 2019-04-03 EA EA202092393A patent/EA202092393A1/ru unknown
- 2019-04-03 CA CA3095866A patent/CA3095866A1/en active Pending
- 2019-04-03 HU HUE19718465A patent/HUE066793T2/hu unknown
- 2019-04-03 MY MYPI2020005118A patent/MY202406A/en unknown
- 2019-04-03 LT LTEPPCT/JP2019/014730T patent/LT3774745T/lt unknown
- 2019-04-03 FI FIEP19718465.8T patent/FI3774745T3/fi active
- 2019-04-03 KR KR1020207031251A patent/KR102764726B1/ko active Active
- 2019-04-03 AU AU2019249562A patent/AU2019249562B2/en active Active
- 2019-04-03 SG SG11202009564TA patent/SG11202009564TA/en unknown
- 2019-04-03 US US17/044,892 patent/US11414391B2/en active Active
- 2019-04-03 DK DK19718465.8T patent/DK3774745T3/da active
- 2019-04-03 CN CN201980022064.2A patent/CN111902402B/zh active Active
- 2019-04-03 ES ES19718465T patent/ES2982586T3/es active Active
- 2019-04-03 EP EP19718465.8A patent/EP3774745B1/en active Active
- 2019-04-03 HR HRP20240858TT patent/HRP20240858T1/hr unknown
- 2019-04-03 KR KR1020257003493A patent/KR20250022254A/ko active Pending
- 2019-04-03 IL IL277730A patent/IL277730B2/en unknown
- 2019-04-03 BR BR112020019377-1A patent/BR112020019377A2/pt active Search and Examination
- 2019-04-03 SI SI201930776T patent/SI3774745T1/sl unknown
-
2020
- 2020-09-30 PH PH12020551605A patent/PH12020551605A1/en unknown
- 2020-10-02 ZA ZA2020/06134A patent/ZA202006134B/en unknown
-
2021
- 2021-12-03 JP JP2021196978A patent/JP2022037040A/ja active Pending
-
2022
- 2022-07-07 US US17/859,675 patent/US11840512B2/en active Active
-
2023
- 2023-10-03 JP JP2023171778A patent/JP2024001115A/ja active Pending
- 2023-10-31 US US18/498,894 patent/US20240076275A1/en not_active Abandoned
-
2024
- 2024-09-24 AU AU2024220015A patent/AU2024220015B2/en active Active
-
2025
- 2025-03-27 US US19/092,743 patent/US20250250243A1/en active Pending
- 2025-06-04 JP JP2025093100A patent/JP2025128238A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL279468A (en) | Crystallographic modifications of odeviccibat | |
| EP3793551A4 (en) | OXADIAZOLE COMPOUNDS | |
| GB201806578D0 (en) | Novel compound | |
| GB201803393D0 (en) | Novel compounds | |
| GB201803394D0 (en) | Novel compounds | |
| PL3827042T3 (pl) | Związek wielo-azyrydynowy | |
| ZA202006134B (en) | Oxazole compound crystal | |
| ZA202101671B (en) | Imidazopyridinone compound | |
| PT3867247T (pt) | Novos compostos | |
| IL285219A (en) | A crystal of the compound diarylthiohydantoin | |
| GB201809378D0 (en) | Novel compounds | |
| GB201818651D0 (en) | Compounds | |
| ZA202100484B (en) | Crystal of benzoxazole derivative | |
| GB201807362D0 (en) | Novel compounds | |
| GB201805602D0 (en) | Novel Compounds | |
| GB201803561D0 (en) | Novel compounds | |
| GB201803411D0 (en) | Novel compounds | |
| GB201803391D0 (en) | Novel compounds | |
| GB201803417D0 (en) | Novel compounds | |
| GB201803413D0 (en) | Novel compounds | |
| GB201803412D0 (en) | Novel compounds | |
| GB201803414D0 (en) | Novel compounds | |
| GB201803415D0 (en) | Novel compounds | |
| GB201803392D0 (en) | Novel compounds | |
| GB201803042D0 (en) | Novel Compounds |